Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021
Persistence Market Research
Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 - 2021
Persistence Market Research
1
Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021 Persistence Market Research Released New Market Report on “Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 - 2021�. Acute Myeloid Leukemia (AML) is classed as an orphans disease. AML is a rare but a severe disease and is a most common leukemia. It is primarily a disease of the elderly, with an average age of diagnosis of approximately 66. AML results from the acquired changes in the DNA of a developing marrow cell. The marrow cells get converted into the leukemic cells, multiplies into 11 billion or more. AML affects the normal cells which are partially developed and further these cells are unable to perform their functions. These cells are known as leukemia blasts. Leukemia blast grows and survives better than normal cells and also blocks the production of normal cells. AML is developed in an individual due to the recurrent exposure to element benzene since benzene damages the DNA of a normal marrow cells. As per the Toxic Substance and Disease registry, petroleum products contributes to the majority of benzene in atmosphere half of the exposure to benzene comes from cigarette smoke. AML cases are also seen in patients undergoing chemotherapy (alkylating agents or topoisomerase II inhibitors) or radiation therapy. People with genetic disorders such as Shwachman syndrome, Down syndrome, Diamond Blackfan Syndrome are associated with a risk of AML. Also people with certain blood disorder can develop AML. According to the American Cancer Society of U.S.A (2015) states that around 54,270 new cases of all kind of Leukemia were detected in 2015, out of which 20,830 cases were found to be of AML and 10,640 deaths were due to AML and. It also states that AML is found to be more common in men than in women. The segmentation of Acute Myeloid Leukemia market is done on the basis of drugs, pipeline analysis and geography. On the basis of drugs it is classified as Daunorubicin, Vidaza, Dagogen, Busulfan, Idarubicin and Others The pipeline analysis is a complete evaluation of the pipeline for AML treatments, with specific analysis of a number of late stage (phase III) pipeline drugs that have the potential to enter the market during the forecast period and early stage (Phase I and Phase II) also. The pipeline is evaluated on the origin of phase distribution, molecule targets, molecular types and administration routes. An added in-depth examination of pipeline drug clinical trials by phase, trial size and trial duration On the basis of the geography, the acute myeloid leukemia market can be classified into North America, Asia Pacific, Latin America, Europe, and Rest of the World. The market of AML is dominated by North America and is followed by Europe and Asia Pacific. North America is reported to have the largest market share due to the aging population and the maximum cases of AML being detected.
Persistence Market Research
2
Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021 Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/7454 The AML market will grow faster in the coming years due to the rising exposure to benzene, increasing incidences of chemotherapy and radiation therapy, Novel drug therapies, increasing aging population and the unmet needs of the market. Whereas increasing number of stem cell transplant, lack of standardized treatment and market being heavily dominated with the generics act as a barrier in the AML market. Request TOC (table of content), Figures http://www.persistencemarketresearch.com/toc/7454
and
Tables
of
the
Report:
The major players in AML market are Johnson & Johnson Private Limited, Pfizer Inc. Abbott, AstraZeneca, Bayer, Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi. For more Info: http://www.persistencemarketresearch.com/contact-us.asp The report covers exhaustive analysis on:
Acute Myeloid Leukemia Market Segments
Acute Myeloid Leukemia Market Dynamics
Historical Actual Market Size, 2012 - 2014
Acute Myeloid Leukemia Market Size & Forecast 2015 to 2025
Supply & Demand Value Chain
Acute Myeloid Leukemia Market Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Acute Myeloid Leukemia Market Drivers and Restraints
Regional analysis for Acute Myeloid Leukemia Market includes
North America
Latin America
Persistence Market Research
3
Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021
Europe
Asia Pacific & Japan
The Middle East and Africa
Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation North America Europe Asia RoW 3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market. Browse the full “All Upcoming Persistence Market's ” report at http://www.persistencemarketresearch.com/forthcoming-reports.asp About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without Persistence Market Research
4
Acute Myeloid Leukemia Market: Global Industry Analysis and Forecast 2015 2021 compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability. PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/
Persistence Market Research
5